Novartis to spin off, list Sandoz business
Novartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it as…
Read MoreNovartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it as…
Read MoreAmericans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MoreAmericans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MorePfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in…
Read MoreFirst lady Jill Biden left isolation on Sunday, after testing negative for COVID twice and…
Read MoreGet ready for a big change in how the U.S. will pay for COVID-19 vaccines…
Read MorePeople who have had COVID-19 are facing a higher risk of neurological and psychiatric conditions…
Read MoreAmerica’s baby-formula shortage appears to be easing. As of Monday, there were 25% more baby-formula…
Read MoreData from a trial seeking to determine whether multiple injections of a tuberculosis vaccine developed…
Read More“Demand keeps rising and it’s no longer certain that we can continue to meet the…
Read More